Contact
Please use this form to send email to PR contact of this press release:
Corbus Pharmaceuticals Initiates “DETERMINE” Phase 3 Study in Dermatomyositis
TO:
Please use this form to send email to PR contact of this press release:
Corbus Pharmaceuticals Initiates “DETERMINE” Phase 3 Study in Dermatomyositis
TO: